Search

everythinglearnresearchcommunity

for

Search:↓

The 2% minoxidil nanosuspension is as effective as the commercial product but safer and easier to use.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

IGF-1 affects hair loss and could be a potential treatment.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Stress worsens hair loss in androgenetic alopecia.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Severe hair loss links to metabolic issues in older men with psoriasis.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

PRP treatment helps hair growth in most cases, but more research needed.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.

The modified hair loss classification is more detailed but less user-friendly.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Sex-determining genes may affect male baldness.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

PRP injections improve hair density in male hair loss.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

MRI helps evaluate androgenetic alopecia severity.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Postoperative folliculitis after hair transplants is a minor issue that doesn't relate to patient details or how much hair is transplanted.

Finasteride 1 mg helps prevent more hair loss in men with male pattern baldness.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Finasteride effectively treats hair loss in Korean men for at least 5 years, with V type responding better.